Intensive care unit management of patients with status epilepticus

Thomas P Bleck*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


The intensive care unit management of status epilepticus focuses on patients who are refractory to initial treatment, who have an underlying condition that require critical care management, or who experience respiratory or cardiovascular complications of their therapies. The available data suggest that failure of a first-line anticonvulsant agent to terminate status should lead to the use of a definitive therapy in general anesthetic doses. Midazolam, propofol, and phenobarbital have been used most frequently; the place of newer agents (e.g., valproate, levetiracetam, or topiramate) remains to be determined.

Original languageEnglish (US)
Pages (from-to)59-60
Number of pages2
Issue numberSUPPL. 8
StatePublished - Nov 1 2007


  • Levetiracetam
  • Lorazepam
  • Midazolam
  • Propofol
  • Status epilepticus
  • Valproate

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology


Dive into the research topics of 'Intensive care unit management of patients with status epilepticus'. Together they form a unique fingerprint.

Cite this